The biotech industry has been under pressure due to the global uncertainty caused by the tariff war. Though pharmaceuticals ...

Although it remains to be seen how well Western will chart its path ... But the loss of Leech comes less than four months after Federal Reserve policy lead and head of US broad markets comanager ...

27, 2024, departure of PGIM Private Alternatives head Eric Adler ... but its Z share class' 3.9% loss in 2008 was not catastrophic. It lagged during the 2013 taper tantrum and the late-2016 ...